Back to Home Page

border

My Story

border

Near fatal Asthma Attack

border

Steps I took to cure asthma

border

About Chlamydia pneumoniae

Research

border

Blood tests

border

My medications

border

Find a doctor

border

Appalachian Trail journey

border

visit the support forum

border

Online pharmacies

border

Other links

border

Contact Us

border




ASTHMA AND INFECTION
RECOMMENDATIONS FOR INTERESTED PHYSICIANS
by DAVID L. HAHN. MD. MS


NEW RESEARCH
Bronchial Lavage of Pediatric Patients with Asthma Contains Infectious Chlamydia


F.A.Q.
Frequently asked questions







EMAIL A FRIEND



With so much information exploding all around us, finding a nugget of knowledge is not nearly as mportant as what you do with it.




  Research abstract:

Chlamydia pneumoniae and exacerbations of asthma in adults.

Miyashita N,      Kubota Y,      Nakajima M,      Niki Y,      Kawane H,      Matsushima T     

Ann Allergy Asthma Immunol (1998 May) 80(5):405-9       ISSN: 1081-1206

Asthma
Chlamydia pneumoniae
Chlamydia Infections
Acute Disease
Adolescence

Adult
Aged
Aged, 80 and over
Antibodies, Bacterial
Female

Human
Male
Middle Age

Abstract
BACKGROUND: Chlamydia pneumoniae is a frequent causative agent of acute respiratory disease and has been recently reported as a possible cause of asthma. 

OBJECTIVE: We assessed the prevalence of C. pneumoniae infections in adult patients with acute exacerbations of asthma. 

METHODS: One hundred sixty-eight adult patients with acute exacerbations of asthma and 108 control subjects matched for age, sex, and smoking status were studied.  Nasopharyngeal swab specimens were obtained from all subjects and analyzed by isolation in cell culture and polymerase chain reaction (PCR) test for C. pneumoniae.  Serum samples were also obtained and tested for C. pneumoniae- specific antibodies by the microimmunofluorescence test. 

RESULTS: C. pneumoniae was isolated from two (1.2%) asthma patients and none from controls and detected by PCR from nine (5.4%) cases and one (0.9%) control.  Both culture positive specimens were also positive in PCR.  Further, serologic evidence of acute C. pneumoniae infection was present in 15 (8.9%) of asthma patients and in three (2.8%) of controls (P = .048).  The prevalence of C. pneumoniae-specific IgG and IgA was significantly higher in asthma cases than in controls (IgG > or = 1:16: 85.1% versus 67.6%, P = .001; IgA > or = 1:16: 47.6% versus 16.7%, P < .001).  Mean titer of IgG and IgA was also significantly greater in asthma cases than in controls (IgG: 38.8 versus 18.1, P = .0001; IgA: 17.2 versus 6.1, P = .0001). 

CONCLUSIONS: Our data suggest that C. pneumoniae infection may trigger acute exacerbations of adult asthma.

Department of Medicine
Kawasaki Medical School
Kurashiki City
Okayama
Japan.